The impact of the COVID-19 pandemic on institutionalization and healthcare costs in memory clinic patients
Journal of Alzheimer’s Disease · 2026-11 · 114 (2) · 689-697
DOI: 10.1177/13872877261486732 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, online erschienen am 09.10.2026. Verfasst von Els D Bakker und 5 weiteren Autor:innen. Beteiligte Einrichtung: Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: COVID-19, Institutionalization, Health Care Costs, Dementia. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.
Abstract (Originalsprache)
Background
The COVID-19 pandemic disrupted healthcare services and daily routines, which may have particularly affected individuals with cognitive impairment or dementia who rely on continuity of care. However, the impact of these disruptions on institutionalization and healthcare costs remains largely unknown.
Objective
We investigated the impact of COVID-19-pandemic on institutionalization and healthcare costs in a mixed memory clinic population, compared to a well-balanced historical control group.
Methods
We included memory clinic patients from the Amsterdam Dementia Cohort: 1) n = 911 pandemic-patients (baseline: 2017–2018, follow-up: until 2021), and 2) n = 821 well-balanced historical controls (baseline: 2015–2016, follow-up: until 2019). Time to institutionalization was analyzed using restricted mean survival time (RMST), and healthcare costs using linear regression with spline knot at 2 years.
Results
We found no difference for time until institutionalization between groups for all diagnoses together. Stratified for syndrome diagnosis, we found that pandemic-patients with dementia (RMST between group contrast (BGC)[95%-CI] = −0.241 year[−0.456 – −0.026], i.e., −2.9 months) and another diagnosis (RMST BGC[95%-CI] = −0.214 year[−0.407 – −0.021], i.e., −2.6 months) had shorter time to institutionalization. Total healthcare costs did not differ between groups ( B [95%-CI] = 302.12 [−1229.17–1833.40], p = 0.699).
Conclusions
In conclusion, we found no indications of a significantly decreased or increased healthcare consumption as a result of COVID-19 pandemic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
- Neurodegeneration, Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
- Northwest Academy, Northwest Clinics Alkmaar, Alkmaar, The Netherlands.
- Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.
- Methodology, Amsterdam Public Health, Methodology, Amsterdam, The Netherlands.
- Alzheimer Nederland, Amersfoort, the Netherlands.
ORCID-Profile: Els D Bakker, Pieter J van der Veere, Ingrid S van Maurik
Förderung
- ZonMw
Zitieren
APA
Bakker, E. D., van der Veere, P. J., Heymans, M. W., van Harten, A. C., van der Flier, W. M., & van Maurik, I. S. (2026). The impact of the COVID-19 pandemic on institutionalization and healthcare costs in memory clinic patients. Journal of Alzheimer’s Disease, 114(2), 689-697. https://doi.org/10.1177/13872877261486732
Vancouver
Bakker ED, van der Veere PJ, Heymans MW, van Harten AC, van der Flier WM, van Maurik IS. The impact of the COVID-19 pandemic on institutionalization and healthcare costs in memory clinic patients. Journal of Alzheimer’s Disease. 2026;114(2):689-697. doi:10.1177/13872877261486732
BibTeX
@article{Bakker2026,
author = {Bakker, Els D and van der Veere, Pieter J and Heymans, Martijn W and van Harten, Argonde C and van der Flier, Wiesje M and van Maurik, Ingrid S},
title = {The impact of the COVID-19 pandemic on institutionalization and healthcare costs in memory clinic patients},
journal = {Journal of Alzheimer’s Disease},
year = {2026},
volume = {114},
number = {2},
pages = {689--697},
doi = {10.1177/13872877261486732}
}
EUVIMED